Assignee
CLINUVEL PHARMACEUTICALS LTD
AU·5 granted patents·4 pending applications·5 citations·filing 2004–2018
Top patents by PatentIndex Score
9 records- 0190US10076555B2Methods of inducing melanogenesis in a subjectCLINUVEL PHARMACEUTICALS LTD·Filed 2016·Granted Sep 18, 2018·2 cites·22 claims
- 0267US9801924B2Therapy for vitiligoCLINUVEL PHARMACEUTICALS LTD·Filed 2013·Granted Oct 31, 2017·1 cites·9 claims
- 0363US11622994B2Therapy for vitiligoCLINUVEL PHARMACEUTICALS LTD·Filed 2017·Granted Apr 11, 2023·0 cites·11 claims
- 0458US2011130705A1Therapy for vitiligoCLINUVEL PHARMACEUTICALS LTD·Filed 2009·Application pending·0 cites
- 0557US10857208B2Methods of inducing melanogenesis in a subjectCLINUVEL PHARMACEUTICALS LTD·Filed 2018·Granted Dec 8, 2020·0 cites·32 claims
- 0656US7745408B2Method of inducing melanogenesis in humans with MC1R variant allelesCLINUVEL PHARMACEUTICALS LTD·Filed 2004·Granted Jun 29, 2010·2 cites·9 claims
- 0750US2010113337A1Method for reducing incidence or rate of development of skin cancers and related conditionsCLINUVEL PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 0846US2013344153A1Method for reducing incidence or rate of development of skin cancers and related conditionsCLINUVEL PHARMACEUTICALS LTD·Filed 2013·Application pending·0 cites
- 0943US2020246436A1Alpha-msh analogues used in the treatment of xeroderma pigmentosumCLINUVEL PHARMACEUTICALS LTD·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →